Reinventing Life Science Startups–Therapeutics and Diagnostics
Steve Blank
AUGUST 19, 2013
But what if we could increase productivity and stave the capital flight by helping Life Sciences startups build their companies more efficiently? Yet during those same 60 years, rather than decreasing, the cost of getting a new drug approved by the FDA has increased 80 fold. Pharma companies are staggering under the costs.
301 
Let's personalize your content